OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
An OpenAI researcher is in talks to leave the company and launch a startup focused on developing AI models for drug discovery, with discussions underway to raise approximately $200 million at a $2 billion valuation. Several other OpenAI researchers are expected to join the new company, which may work on AI models to find new uses for existing drugs and those that previously failed in trials. This reflects investor interest in applying AI to breakthroughs in life sciences, as other well-funded startups in this space have recently announced major funding rounds. The researcher joined OpenAI in 2024 after dropping out of Harvard and has co-authored research papers on how AI models can accelerate scientific discovery.
One short email a day with the stories that matter. Free. Unsubscribe with one click.
Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.
Browse AI courses on Maven
Anthropic sets IPO price range of $70 to $78 per share to reach an implied valuation of $1.404 trillion
The company could end up being worth a hefty $1.404 trillion if its shares list at the top of the price range, on a fully diluted basis.
Also reported by SiliconANGLE
Anthropic pushes ahead with pre-Thanksgiving IPO despite tech selloff, accepts lower valuation
Despite the tech selloff, Anthropic is pressing ahead with its IPO at a valuation of $1.25 to $1.75 trillion, well below the hoped-for $2 trillion. The Claude developer aims to raise $80 to $100 billion before Thanksgiving. Rival OpenAI has also recently had to cut its valuation. The article Anthropic pushes ahead with pre-Thanksgiving IPO despite tech selloff, accepts lower valuation appeared first on The Decoder.
Also reported by TechCrunch and The Verge
Taiwan’s chipmaking giant TSMC to invest $1B in Anthropic, OpenAI
Top chip manufacturer TSMC is ready to invest $1 billion in Anthropic and OpenAI. That would give the Taiwanese chipmaker direct stakes in leading AI developers, even as its own contract chipmaking business has profited enormously from the AI data center buildout. The chipmaker’s board approved plans to invest up to $500 million in OpenAI preferred stock reserved for large investors and another $500 million to purchase Anthropic common shares at the latter’s expected IPO price, according to Reut
OpenAI lands an $11 billion funding round, but has to court dentists for more capital
OpenAI has secured $11 billion in fresh capital, the first tranche of a round that values the company at $1.25 trillion. The full round could swell to $20 billion. That OpenAI is already turning to wealthy private investors hints at a saturating AI capital market and growing investor caution. The article OpenAI lands an $11 billion funding round, but has to court dentists for more capital appeared first on The Decoder.
Hatz AI raises $24M to help small businesses go AI-native through their MSPs
Large enterprises have emerged as the foremost adopters of artificial intelligence technology, and it’s giving them an unfair advantage over their smaller competitors. Looking to change that is a startup called Hatz AI Inc., which has just raised $24 million in early-stage funding to empower managed services providers with the tools they need to keep […] The post Hatz AI raises $24M to help small businesses go AI-native through their MSPs appeared first on SiliconANGLE.
Anthropic Seeks Record $88.5B Tied To Public Market Debut
Anthropic is seeking to secure up to $88.5 billion in its planned IPO and a concurrent private placement, potentially making it the largest-ever fundraise tied to a public market debut. On Tuesday, the AI giant submitted an updated S-1 filing for its upcoming public offering, unveiling new details including a proposed share price range offering size. The offering could set a fully diluted valuation of up to $1.4 trillion for the San Francisco company. Anthropic’s expected valuation comes in belo